Prof. Dr. ERKAN DEREBEK

Yayın Ağı

Makaleler 44

1. Pathologic Complete Response as a Prognostic Indicator in Bridging Therapy: A 25-Year Retrospective Study on Hepatocellular Carcinoma and Liver Transplantation Outcomes

Agalar C., Egeli T., Ozbilgin M., Sakaoglu B., Aysal A., Astarcioglu I., et al.

Transplantation Proceedings , cilt.57, sa.9, ss.1768-1772, 2025 (SCI-Expanded)

2. Machine Learning using MR İmaging Radiomics can Predict the Response of Large Hepatocellular Carcinoma to Transarterial Radioembolization

SARIOĞLU O., CANTÜRK A., YAROL R. C., Gulmez H., SARIOĞLU F. C., DEREBEK E., et al.

NIGERIAN JOURNAL OF CLINICAL PRACTICE , cilt.28, sa.9, ss.1111-1120, 2025 (SCI-Expanded)

3. Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival

SOYDAL Ç., ARAZ M., Demir B., ÖNEŞ T., SÖNMEZOĞLU K., Selcuk N. A., et al.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine , cilt.66, sa.7, ss.1097-1104, 2025 (SCI-Expanded)

4. An Unusual Ectopic Parathyroid Adenoma Location: Pyriform Sinus

Oncul E. C., Semiz G., DEREBEK E., Dogan E.

TURKISH ARCHIVES OF OTORHINOLARYNGOLOGY , cilt.63, sa.2, ss.95-98, 2025 (ESCI)

5. The role of volumetric and textural analysis of pretreatment F-18-fluorodeoxyglucose PET/computerized tomography images in predicting complete response to transarterial radioembolization in hepatocellular cancer

KARAHAN ŞEN N. P., ALATAŞ Ö., GÜLCÜ A., ÖZDOĞAN Ö., DEREBEK E., ÇAPA KAYA G.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.43, sa.7, ss.807-814, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

6. The use of molecular volumetric parameters for the evaluation of Lu-177 PSMA I&T therapy response and survival

Acar E., ÖZDOĞAN Ö., Aksu A., DEREBEK E., BEKİŞ R., Kaya G. C.

ANNALS OF NUCLEAR MEDICINE , cilt.33, sa.9, ss.681-688, 2019 (SCI-Expanded)

7. Lu-177 PSMA I&T Therapy for Prostate Cancer; Treatment Response, Treatment Toxicity, and Survival Results

Acar E., Sonmezer B., DEREBEK E., BEKİŞ R., ÖZDOĞAN Ö., Kaya G. C.

JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES , cilt.3, sa.3, ss.158-164, 2019 (ESCI) Sürdürülebilir Kalkınma

8. The use of pre-test and post-test probability values as criteria before selecting patients to undergo coronary angiography in patients who have ischemic findings on myocardial perfusion scintigraphy

Sen N. P., BEKİŞ R., Ceylan A., DEREBEK E.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.16, sa.7, ss.512-519, 2016 (SCI-Expanded)

9. The Effects of the Factors Related to the Patient and the Disease on the Performance of Ablation Therapy in Patients with Differentiated Thyroid Cancer who have Received I-131 Ablation Therapy

Sengoz T., Surucu E., Demir Y., DEREBEK E.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.21, sa.3, ss.103-109, 2012 (ESCI)

10. Baker's Cyst on F-18 FDG PET/CT in a Patient with Ocular Melanoma

Cayvarli H., DEREBEK E.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.21, sa.2, ss.75-76, 2012 (ESCI)

11. ^99mTc sestamibi scintimammography - Screening mammographic non-palpable suspicious breast lesions: preliminary results

BEKİŞ R., Derebek E., Balci P., Kocdor M. A., Degirmenci B., Canda T., et al.

NUKLEARMEDIZIN-NUCLEAR MEDICINE , cilt.43, sa.1, ss.16-20, 2004 (SCI-Expanded) Sürdürülebilir Kalkınma

12. 99mTc sestamibi scintimammography. Screening mammographic non-palpable suspicious breast lesions: Preliminary results 99mTc-sestamibiszintigraphie: Mammographie-screening nicht palpabler verdächtiger brustläsionen, vorläufige ergebnisse

Bekiş R., Derebek E., Balci P., Koçdor M. A., Değirmenci B., Canda T., et al.

NuklearMedizin , cilt.43, sa.1, ss.16-20, 2004 (SCI-Expanded)

13. Correlation of Tc-99m MIBI uptake with estrogen receptor, progesterone receptor, histological grade, nuclear grade and mitotic index in invazive ductal breast cancer:: Preliminary results

BEKİŞ R., Derebek E., Ozkal S., Kocdor M. A., Canda T., Durak H.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.28, sa.8, ss.1121, 2001 (SCI-Expanded)

14. Tc-99m HMPAO brain perfusion SPECT in drug-free obsessive-compulsive patients without depression

ALPTEKİN K., Degirmenci B., Kivircik B. B., Durak H., Yemez B., Derebek E., et al.

PSYCHIATRY RESEARCH-NEUROIMAGING , cilt.107, sa.1, ss.51-56, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma

15. Bilateral asynchronous perinatal testicular torsion:: A case report

OLGUNER M., Akgur F., Aktug T., Derebek E.

JOURNAL OF PEDIATRIC SURGERY , cilt.35, sa.9, ss.1348-1349, 2000 (SCI-Expanded) Sürdürülebilir Kalkınma

16. Recanalized umbilical vein in a patient with multifocal malignant schwannoma

ÇAPA KAYA G., Yilmaz M., Derebek E., Kocdor M. A., Dicle O., Durak H.

CLINICAL NUCLEAR MEDICINE , cilt.25, sa.9, ss.747-748, 2000 (SCI-Expanded) Sürdürülebilir Kalkınma

17. Technetium-99m DTPA inhalation scintigraphy in patients treated with fluoxetine and maprotiline:: preliminary results

ÇAPA KAYA G., Durak H., Yemez B., Turhal U., Ozdogan Ö., Sayit E., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.27, sa.9, ss.1402-1404, 2000 (SCI-Expanded) Sürdürülebilir Kalkınma

18. Evaluation of hepatic hemangioma with technetium-99m RBC scintigraphy: A review of 74 cases with liver masses

YILMAZ M., DEREBEK E., DİCLE O., Degirmenci B., Sayit E., Capa G., et al.

Turkish Journal of Gastroenterology , cilt.11, sa.1, ss.61-68, 2000 (Scopus)

19. Effect of fluoxetine and maprotiline on pulmonary epithelial permeability

Capa G., Durak H., Yemez B., Turhal U., Ozdogan Ö., Degirmenci B., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.26, sa.9, ss.1035, 1999 (SCI-Expanded)

20. Tc-99m tetrofosmin myocardial perfusion scintigraphy to detect restenosis after stent implantation and percutaneous coronary angioplasty (PTCA)

Degirmenci B., Kirimli O., BEKİŞ R., Capa G., Derebek E., Goldeli O., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.26, sa.9, ss.1061, 1999 (SCI-Expanded)

21. Detection of bilateral multifocal breast cancer using Tc-99m sestamibi imaging - The role of delayed imaging

Derebek E., Balci P., Alanyali H., Kocdor M. A., Capa G., Gorken İ., et al.

CLINICAL NUCLEAR MEDICINE , cilt.24, sa.8, ss.590-593, 1999 (SCI-Expanded) Sürdürülebilir Kalkınma

22. Indium-111 octreotide uptake in the surgical scar

Degirmenci B., BEKİŞ R., Sen M., Durak H., Derebek E.

NUKLEARMEDIZIN , cilt.38, sa.7, ss.306-308, 1999 (SCI-Expanded) Sürdürülebilir Kalkınma

23. Technetium-99m-tetrofosmin scintigraphy in pulmonary tuberculosis

Degirmenci B., Kilinc O., Cirak K., Capa G., Akpinar O., Halilcolar H., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.39, sa.12, ss.2116-2120, 1998 (SCI-Expanded) Sürdürülebilir Kalkınma

24. Technetium-99m sestamibi uptake in hepatocellular carcinoma

Derebek E.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.25, sa.11, ss.1587-1588, 1998 (SCI-Expanded) Sürdürülebilir Kalkınma

25. Tc-99m sestamibi imaging as an indicator of P-glycoprotein expression in metastatic pheochromocytoma

Derebek E., Capa G., BERK R. H., Sekeroglu B., Havitcioglu H., Degirmenci B., et al.

CLINICAL NUCLEAR MEDICINE , cilt.23, sa.9, ss.637-638, 1998 (SCI-Expanded) Sürdürülebilir Kalkınma

26. Chemotherapy and uptake of technetium-99m sestamibi in breast cancer [5]

DEREBEK E.

European Journal of Nuclear Medicine , cilt.25, sa.4, ss.448, 1998 (SCI-Expanded) Sürdürülebilir Kalkınma

27. The effect of coronary artery bypass surgery on brain perfusion

Degirmenci B., Durak H., Hazan E., Karabay O., Derebek E., Yilmaz M., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.39, sa.4, ss.587-591, 1998 (SCI-Expanded) Sürdürülebilir Kalkınma

28. Chemotherapy and uptake of technetium-99m sestamibi in breast cancer

Derebek E.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.25, sa.4, ss.448, 1998 (SCI-Expanded) Sürdürülebilir Kalkınma

29. Serum vitamin A and β-carotene concentrations and renal scarring in urinary tract infections

Kavukcu S., Turkmen M., Sevinc N., Soylu A., Derebek E., Buyukgebiz B.

ARCHIVES OF DISEASE IN CHILDHOOD , cilt.78, sa.3, ss.271-272, 1998 (SCI-Expanded, Scopus)

30. Infusion versus bolus injection of Tc-99m tetrofosmin in the identification of viable myocardium

Derebek E., Kozan O., Durak H., ÇAPA KAYA G., Capa G., Ozbilek E., et al.

CLINICAL NUCLEAR MEDICINE , cilt.23, sa.3, ss.146-149, 1998 (SCI-Expanded) Sürdürülebilir Kalkınma

31. Indium 111 octreotide scintigraphy in angiofibroma

Guneri E. A., Degirmenci B., Durak H., Ikiz A., Derebek E., Sutay S.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY , cilt.118, sa.1, ss.137-139, 1998 (SCI-Expanded) Sürdürülebilir Kalkınma

32. Liver and lung metastases of high-grade astrocytoma showing abnormal Tc-99m MDP localization

Yilmaz M., Dogan A., Derebek E., Durak H.

CLINICAL NUCLEAR MEDICINE , cilt.22, sa.7, ss.505-506, 1997 (SCI-Expanded) Sürdürülebilir Kalkınma

33. Wash-out kinetics of Tc-99m-MIBI and the scintigraphic determination of PGP expression

Derebek E., Degirmenci B., Durak H.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.24, sa.6, ss.706, 1997 (SCI-Expanded) Sürdürülebilir Kalkınma

34. Tc-99m MIBI Scintigraphy in the Evaluation of Inflamatory Breast Cancer

DEREBEK E., ÖZSAN G. H., DEĞİRMENCİ B., DOĞAN S., BALCI P., YILMAZ M., et al.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.6, sa.3, ss.210-214, 1997 (ESCI) Sürdürülebilir Kalkınma

35. Sublingual nitrate plus Tc-99(m)-tetrofosmin infusion in the detection of severely ischaemic but viable myocardium: A comparative study with stress, redistribution, reinjection and late redistribution Tl-201 imaging

Derebek E., Kozan O., Durak H., Ergene O., Ozbilek E., Capa G., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.17, sa.10, ss.864-871, 1996 (SCI-Expanded) Sürdürülebilir Kalkınma

36. Tc-99m-MIBI scintigraphy in metastatic renal cell carcinoma: Clinical validation of the relationship between Tc-99m-MIBI uptake and P-glycoprotein expression in tumour tissue

Derebek E., Kirkali Z., Dogan A., Degirmenci B., Yilmaz M., Igci E., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.23, sa.8, ss.976-979, 1996 (SCI-Expanded) Sürdürülebilir Kalkınma

37. Early and delayed thallium-201 scintigraphy in thyroid nodules: The relationship between early thallium-201 uptake and perfusion

Derebek E., Biberoglu S., Kut O., Yesil S., Saydam S., Yilmaz M., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.23, sa.5, ss.504-510, 1996 (SCI-Expanded) Sürdürülebilir Kalkınma

38. Sublingual nitroglycerine plus Tc-99m tetrofosmin infusion in the detection of severely ischemic but viable myocardium

Derebek E., Kozan O., Durak H., Ergene O., Ozbilek E., Capa G., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.37, sa.5, ss.1408, 1996 (SCI-Expanded)

39. Sublingual nitrate plus 99tcm-tetrofosmin infusion in the detection of severely ischaemic but viable myocardium a comparative study with stress, redistribution, reinjection and late redistribution 201T1 imaging

DEREBEK E., Durak H., Ozbilek E., Capa G., Yurekli Y., Degirmenci B., et al.

Nuclear Medicine Communications , cilt.17, sa.10, ss.864-871, 1996 (SCI-Expanded)

40. Prognostic factors in lung cancer with brain metastasis

Sen M., Alanyali H., Cetingoz R., Demiral A. N., Osma E., Akkoclu A., et al.

EUROPEAN JOURNAL OF CANCER , cilt.31A, ss.149, 1995 (SCI-Expanded)

41. Ipsilateral thigh hyperperfusion during acute testicular torsion: An incidental finding related to vascular reflex

DEREBEK E., Akgur F., Kut O., Durak H.

Clinical Nuclear Medicine , cilt.20, sa.6, ss.554-556, 1995 (SCI-Expanded)

42. TL-201 UPTAKE IN THE ORBITS

DURAK H., DURAK I., DEREBEK E., KAYNAK S., METIN E., ERGIN M.

CLINICAL NUCLEAR MEDICINE , cilt.20, sa.6, ss.531-533, 1995 (SCI-Expanded) Sürdürülebilir Kalkınma

43. SCANNING THE THYROID WITH TECHNETIUM-99M-PERTECHNETATE

DEREBEK E., OZKILIC H.

JOURNAL OF NUCLEAR MEDICINE , cilt.33, sa.9, ss.1722-1723, 1992 (SCI-Expanded) Sürdürülebilir Kalkınma

44. EXERCISE WHOLE-BODY TL-201 SCINTIGRAPHY IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS

DEREBEK E., DUMAN Y., OZMEN B., BURAK Z., ERDEM S., KAYALIOGLU M., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.19, sa.8, ss.678, 1992 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 4

1. Transarterial radioembolization (TARE) inCOlorectalMEtastasis of liver (TACOME) Trial

SOYDAL Ç., ARAZ M., DEMİR B., ÖNEŞ T., SÖNMEZOĞLU K., Selcuk N. A., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Almanya, 19 - 23 Ekim 2024, cilt.51, (Özet Bildiri)

2. A rare case recurrence of cecal SCC on PET/CT

Aksu A., KARAHAN ŞEN N. P., DEREBEK E.

8th Balkan congress of nuclear medicine, 10 - 14 Nisan 2019, (Özet Bildiri)

3. The Role of the Experience of Nuclear Medicine Physician on Selection of Patients for Minimally Invasive Parathyroidectomy: Institutional Experience

Ozdogan O., Ayhan S., AKINCI B., BEKİŞ R., ÇAPA KAYA G., Comlekci A., et al.

23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Avusturya, 9 - 13 Ekim 2010, cilt.37, (Özet Bildiri)

4. Detection of sentinel lymph node in breast carcinoma using method of different injection techniques of Tc-99m nanocolloid

BEKİŞ R., Kocdor M. A., Tasci C., Ozdogan Ö., Sevinc A. İ., Canda T., et al.

17th Annual Congress of the European-Association-of-Nuclear-Medicine, Helsinki, Finlandiya, 4 - 08 Eylül 2004, cilt.31, (Özet Bildiri)

Yayınlar & Eserler